CoreCap Advisors’s Erasca ERAS Stock Holding History

CoreCap Advisors’s Portfolio ERAS Stock Details ERAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-100	Closed	-$251	–	3183
2024 Q4	$251	Buy	+100	New	+$274	﹤0.01%	2689

Other funds holding ERAS

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

CoreCap Advisors's ERAS Position: Q1 2025 in Review

CoreCap Advisors sold out of Erasca (ERAS) in Q1 2025, closing a stake of 100 shares — an estimated $251 sold.

CoreCap Advisors first reported a position in ERAS in Q4 2024 and held it in 1 quarter. The position peaked at $251 in Q4 2024. 154 funds tracked by Wall St. Rank hold ERAS as of Q1 2025.

CoreCap Advisors reported no remaining Erasca position as of Q1 2025 after selling out during the quarter.
CoreCap Advisors sold 100 Erasca shares in Q1 2025, an estimated $251.
CoreCap Advisors first reported a position in Erasca in Q4 2024 and held it in 1 quarter.
CoreCap Advisors's Erasca position peaked at $251 in Q4 2024.
154 funds tracked by Wall St. Rank held Erasca as of Q1 2025.

Based on CoreCap Advisors's 13F filing for Q1 2025, filed 9 May 2025.